Bioxyne Limited (ASX:BXN)
Australia · Delayed Price · Currency is AUD 0.0400
+0.0010 (2.56%)
Jan 29, 2026, 4:10 PM AEST
Bioxyne Revenue
In the fiscal year ending June 30, 2025, Bioxyne had annual revenue of 29.28M AUD with 203.66% growth. Bioxyne had revenue of 16.71M in the half year ending June 30, 2025.
Revenue
29.28M
Revenue Growth
+203.66%
P/S Ratio
3.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
89.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 29.28M | 19.64M | 203.66% |
| Jun 30, 2024 | 9.64M | 4.34M | 81.98% |
| Jun 30, 2023 | 5.30M | 4.84M | 1,042.88% |
| Jun 30, 2022 | 463.64K | -1.74M | -78.97% |
| Jun 30, 2021 | 2.20M | -130.94K | -5.61% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Noumi | 595.84M |
| SPC Global Holdings | 319.98M |
| Bubs Australia | 102.54M |
| Clover Corporation | 86.00M |
| Maggie Beer Holdings | 76.32M |
| Jatcorp | 34.84M |
| Nuchev | 22.94M |
| Biome Australia | 18.42M |
Bioxyne News
- 1 year ago - Bioxyne Delivers Australia's First Pharmaceutical Cannabis Gummies, Scales Up Manufacturing Capabilities - Benzinga